Infectious Disease Vaccines: Pricing and Reimbursement Strategies for Access to Emerging MarketsDecision Resources
June 1, 2011
More Infectious Diseases reports by Decision Resources
Hospital-Treated Infections by Decision Resources
Hospital-treated infections (HTIs) constitute a high-value segment of the antibacterial market owing to their relatively high incidence. In addition, unlike infections treated ...
Community-Acquired Bacterial Pneumonia by Decision Resources
The community-acquired bacterial pneumonia (CABP) market is highly genericized, and most pathogens can be treated with currently marketed antibiotics. However, thought leaders agree ...
TreatmentTrends®: MRSA and Serious Gram-Positive Infections (EU) 2012 by Decision Resources
This report provides insight into the management of patients with serious Gram-positive (GP) infections in the hospital setting and analyzes the hospital antibiotic prescribing practices ...
Hospital-Acquired Infections: How is the U.S. Launch of Premium-Priced Antibiotics for C. difficile and MRSA Affecting Physician Prescribing and Payer Reimbursement Decisions? by Decision ResourcesSee all reports like this >>
The market for hospital-treated MRSA infections is dominated by generically available vancomycin; however, several highly efficacious brands compete in later lines of therapy. ...
We can help you find what you need. Call us or write us:
Need help in your search?
Infectious Diseases Reports